Statins and Hepatocellular Carcinoma Protection.
作者信息
Kaplan David E
机构信息
Associate Professor of Medicine Perelman School of Medicine at the University of Pennsylvania Philadelphia, Pennsylvania.
出版信息
Gastroenterol Hepatol (N Y). 2019 Apr;15(4):190-193.
Abstract
摘要
相似文献
1
Statins and Hepatocellular Carcinoma Protection.他汀类药物与肝细胞癌保护作用
Gastroenterol Hepatol (N Y). 2019 Apr;15(4):190-193.
2
A Meta-Analysis of Statin Use and Risk of Hepatocellular Carcinoma.他汀类药物使用与肝细胞癌风险的荟萃分析。
Can J Gastroenterol Hepatol. 2022 Mar 20;2022:5389044. doi: 10.1155/2022/5389044. eCollection 2022.
3
[Meta-analysis of the effects of statins on the risk of chronic liver disease and hepatocellular carcinoma].[他汀类药物对慢性肝病和肝细胞癌风险影响的荟萃分析]
Zhonghua Gan Zang Bing Za Zhi. 2021 Jul 20;29(7):696-701. doi: 10.3760/cma.j.cn501113-20200311-00108.
4
Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin.通过纠正代谢异常预防肝细胞癌：他汀类药物和二甲双胍的作用
World J Hepatol. 2015 May 18;7(8):1105-11. doi: 10.4254/wjh.v7.i8.1105.
5
Statins in Hepatitis B or C Patients Is Associated With Reduced Hepatocellular Carcinoma Risk: A Systematic Review and Meta-Analysis.他汀类药物在乙型或丙型肝炎患者中与降低肝细胞癌风险相关：系统评价和荟萃分析。
Turk J Gastroenterol. 2022 Feb;33(2):136-144. doi: 10.5152/tjg.2020.19656.
6
Effects of statins on the risk of hepatocellular carcinoma.他汀类药物对肝细胞癌风险的影响。
Gastroenterol Hepatol (N Y). 2014 Jul;10(7):417-26.
7
Potential for statins in the chemoprevention and management of hepatocellular carcinoma.他汀类药物在肝细胞癌的化学预防和治疗中的潜力。
J Gastroenterol Hepatol. 2012 Nov;27(11):1654-64. doi: 10.1111/j.1440-1746.2012.07232.x.
8
[Advances and controversies of statins application in prevention and treatment of hepatocellular carcinoma].[他汀类药物在肝细胞癌防治中的应用进展与争议]
Zhonghua Zhong Liu Za Zhi. 2021 Jul 23;43(7):751-755. doi: 10.3760/cma.j.cn112152-20190216-00090.
9
Prevention of Hepatocellular Carcinoma by Statins: Clinical Evidence and Plausible Mechanisms.他汀类药物预防肝细胞癌：临床证据和可能的机制。
Semin Liver Dis. 2019 May;39(2):141-152. doi: 10.1055/s-0039-1679956. Epub 2019 Mar 25.
10
Can Statin Treatment Reduce the Risk of Hepatocellular Carcinoma? A Systematic Review and Meta-Analysis.他汀类药物治疗能否降低肝细胞癌风险？系统评价和荟萃分析。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820934881. doi: 10.1177/1533033820934881.
引用本文的文献
1
Statins in Cirrhosis: Hope or Hype?肝硬化中的他汀类药物：希望还是炒作？
J Clin Exp Hepatol. 2023 Nov-Dec;13(6):1032-1046. doi: 10.1016/j.jceh.2023.05.002. Epub 2023 May 12.
2
Statin use is associated with the reduction in hepatocellular carcinoma recurrence after liver surgery.他汀类药物的使用与肝手术后肝细胞癌复发的减少有关。
BMC Cancer. 2022 Jan 21;22(1):91. doi: 10.1186/s12885-022-09192-1.
本文引用的文献
1
Effects of Hypercholesterolemia and Statin Exposure on Survival in a Large National Cohort of Patients With Cirrhosis.高胆固醇血症和他汀类药物暴露对大型全国肝硬化患者队列生存的影响。
Gastroenterology. 2019 May;156(6):1693-1706.e12. doi: 10.1053/j.gastro.2019.01.026. Epub 2019 Jan 18.
2
Statin Use After Diagnosis of Hepatocellular Carcinoma Is Associated With Decreased Mortality.诊断为肝细胞癌后使用他汀类药物与降低死亡率相关。
Clin Gastroenterol Hepatol. 2019 Sep;17(10):2117-2125.e3. doi: 10.1016/j.cgh.2018.12.046. Epub 2019 Jan 6.
3
Statin attenuates cell proliferative ability via TAZ (WWTR1) in hepatocellular carcinoma.他汀类药物通过TAZ（WWTR1）减弱肝癌细胞的增殖能力。
Med Oncol. 2016 Nov;33(11):123. doi: 10.1007/s12032-016-0845-6. Epub 2016 Oct 12.
4
Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis.辛伐他汀联合标准疗法预防静脉曲张再出血不能降低再出血率，但可提高肝硬化患者生存率。
Gastroenterology. 2016 May;150(5):1160-1170.e3. doi: 10.1053/j.gastro.2016.01.004. Epub 2016 Jan 14.
5
Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis.他汀类药物与乙型肝炎感染人群的肝细胞癌和死亡风险：倾向评分标志分析。
J Hepatol. 2015 Nov;63(5):1190-7. doi: 10.1016/j.jhep.2015.07.009. Epub 2015 Jul 21.
6
Statin use and risk of hepatocellular carcinoma in a U.S. population.美国人群中他汀类药物的使用与肝细胞癌风险
Cancer Epidemiol. 2014 Oct;38(5):523-7. doi: 10.1016/j.canep.2014.06.009. Epub 2014 Aug 10.
7
Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes.在一大群糖尿病患者中，他汀类药物与肝细胞癌风险降低相关。
Gastroenterology. 2009 May;136(5):1601-8. doi: 10.1053/j.gastro.2009.01.053. Epub 2009 Jan 30.
Zotero 插件